Evidence map›Paper›PMID 36916131›Full record

ArticleAnalytical chemistry2023

Digital and Analog Detection of SARS-CoV-2 Nucleocapsid Protein via an Upconversion-Linked Immunosorbent Assay.

Julian C Brandmeier, Natalia Jurga, Tomasz Grzyb, Antonín Hlaváček, Radka Obořilová, Petr Skládal, Zdeněk Farka, Hans H Gorris

Open access · hybridFull text read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Bright photon upconversion in LiYbFJournal of colloid and interface science · 2023
    Article
  12. Recent Trends in Lateral Flow Immunoassays with Optical Nanoparticles.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Julian C BrandmeierDepartment of Biochemistry, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0001-8650-0492
Natalia JurgaDepartment of Biochemistry, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.
Tomasz GrzybDepartment of Rare Earths, Faculty of Chemistry, Adam Mickiewicz University, Poznań, 61614 Poznań, Poland.
Antonín HlaváčekInstitute of Analytical Chemistry of the Czech Academy of Sciences, 602 00 Brno, Czech Republic.
Radka ObořilováDepartment of Biochemistry, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0001-8711-2002
Petr SkládalDepartment of Biochemistry, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.
Zdeněk FarkaDepartment of Biochemistry, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0002-6842-7081
Hans H GorrisDepartment of Biochemistry, Faculty of Science, Masaryk University, 625 00 Brno, Czech Republic.ORCID 0000-0003-1148-4293
Masaryk University · CZCentral European Institute of Technology · CZAdam Mickiewicz University in Poznań · PLCzech Academy of Sciences, Institute of Analytical Chemistry · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 crisis requires fast and highly sensitive tests for the early stage detection of the SARS-CoV-2 virus. For detecting the nucleocapsid protein (N protein), the most abundant viral antigen, we have employed upconversion nanoparticles that emit short-wavelength light under near-infrared excitation (976 nm). The anti-Stokes emission avoids autofluorescence and light scattering and thus enables measurements without optical background interference. The sandwich upconversion-linked immunosorbent assay (ULISA) can be operated both in a conventional analog mode and in a digital mode based on counting individual immune complexes. We have investigated how different antibody combinations affect the detection of the wildtype N protein and the detection of SARS-CoV-2 (alpha variant) in lysed culture fluid via the N protein. The ULISA yielded a limit of detection (LOD) of 1.3 pg/mL (27 fM) for N protein detection independent of the analog or digital readout, which is approximately 3 orders of magnitude more sensitive than conventional enzyme-linked immunosorbent assays or commercial lateral flow assays for home testing. In the case of SARS-CoV-2, the digital ULISA additionally improved the LOD by a factor of 10 compared to the analog readout.

Indexed as

COVID-19ImmunosorbentsAntibodies, ViralEnzyme-Linked Immunosorbent AssayHumansNucleocapsid ProteinsSARS-CoV-2Sensitivity and SpecificityAntibodies, ViralImmunosorbentsNucleocapsid Proteins

Identifiers

PMID36916131
PMCPMC10018451
OpenAlexW4322491743

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read33
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.